Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Finerenone FIRST (Finerenone Research of Early Safety and Effectiveness), Part 2.0

NCT05703880 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05703880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05703880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Finerenone FIRST (Finerenone Research of Early Safety and Effectiveness), Part 2.0
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
June 1, 2023
Completion date
October 1, 2024
Enrollment
15,948 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, type 2 diabetes mellitus